Comparing DuoNeb vs Xopenex
DuoNeb (albuterol / ipratropium) | Xopenex (levalbuterol) |
|
---|
DuoNeb (albuterol / ipratropium) | Xopenex (levalbuterol) |
|
---|---|---|
Prescription only
Prescribed for COPD - Maintenance. DuoNeb may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for COPD, Asthma, Asthma - acute, Asthma - Maintenance, COPD - Maintenance, COPD - Acute. Xopenex may also be used for purposes not listed in this medication guide. |
Related suggestions COPD, Maintenance
Popular comparisons
|
More about DuoNeb (albuterol / ipratropium) | More about Xopenex (levalbuterol) | |
Ratings & Reviews | ||
DuoNeb has an average rating of 9.5 out of 10 from a total of 4 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Xopenex has an average rating of 9.0 out of 10 from a total of 15 ratings on Drugs.com. 93% of reviewers reported a positive effect, while 7% reported a negative effect. |
|
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all DuoNeb side effects |
View all Xopenex side effects |
|
Drug Class | ||
Generic Availability | ||
Lower cost generic approved |
N/A |
|
Pricing and Coupons * Prices are without insurance | ||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
Dosage Forms | ||
|
|
|
Brand Names | ||
Other albuterol / ipratropium brands include: Combivent, Combivent Respimat | Other levalbuterol brands include: Xopenex Concentrate, Xopenex HFA | |
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
6.5 hours |
4 hours |
|
CSA Schedule 1 View glossary of CSA terms | ||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
Pregnancy Category | ||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
|
Drug Interactions | ||
A total of 490 drugs are known to interact with DuoNeb:
|
A total of 360 drugs are known to interact with Xopenex:
|
|
Alcohol/Food/Lifestyle Interactions | ||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
Disease Interactions | ||
First Approval Date | ||
March 21, 2001 |
March 25, 1999 |
|
WADA Class View classifications | ||
N/A |
N/A |
|
More Information | ||
Patient Resources | ||
Professional Resources | ||
Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Symbicort
Symbicort (budesonide and formoterol) is used to prevent bronchospasm in people with asthma or ...
Ventolin
Ventolin is used for asthma, acute, asthma, maintenance, bronchiectasis, bronchospasm prophylaxis ...
Breztri Aerosphere
Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler used for the ...
Ventolin HFA
Ventolin HFA (albuterol) is used to treat or prevent breathing problems in patients who have asthma ...
Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is used to prevent airflow obstruction or bronchospasm in ...
Spiriva
Spiriva (tiotropium) is used to prevent bronchospasm in people with bronchitis, emphysema, or COPD ...
Anoro Ellipta
Anoro (umeclidinium and vilanterol inhalation powder) is used to treat chronic obstructive ...
Xopenex
Xopenex is a short-acting bronchodilator used to treat or prevent bronchospasm in asthma and other ...
Combivent
Combivent Respimat is used to prevent bronchospasm in people with chronic obstructive pulmonary ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.